BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34465178)

  • 1. Mutational Signatures: From Methods to Mechanisms.
    Kim YA; Leiserson MDM; Moorjani P; Sharan R; Wojtowicz D; Przytycka TM
    Annu Rev Biomed Data Sci; 2021 Jul; 4():189-206. PubMed ID: 34465178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
    Phillips DH
    DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RepairSig: Deconvolution of DNA damage and repair contributions to the mutational landscape of cancer.
    Wojtowicz D; Hoinka J; Amgalan B; Kim YA; Przytycka TM
    Cell Syst; 2021 Oct; 12(10):994-1003.e4. PubMed ID: 34375586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying mutational signatures in human cancers.
    Helleday T; Eshtad S; Nik-Zainal S
    Nat Rev Genet; 2014 Sep; 15(9):585-98. PubMed ID: 24981601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational approaches for discovery of mutational signatures in cancer.
    Baez-Ortega A; Gori K
    Brief Bioinform; 2019 Jan; 20(1):77-88. PubMed ID: 28968631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decomposing the mutational landscape of cancer genomes with RepairSig.
    Bernardo S; Meyenberg M; Loizou JI
    Cell Syst; 2021 Oct; 12(10):953-955. PubMed ID: 34672958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Repair Footprint Uncovers Contribution of DNA Repair Mechanism to Mutational Signatures.
    Wojtowicz D; Leiserson MDM; Sharan R; Przytycka TM
    Pac Symp Biocomput; 2020; 25():262-273. PubMed ID: 31797602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating the concept of mutational signatures with isogenic cell models.
    Zou X; Owusu M; Harris R; Jackson SP; Loizou JI; Nik-Zainal S
    Nat Commun; 2018 May; 9(1):1744. PubMed ID: 29717121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational signature distribution varies with DNA replication timing and strand asymmetry.
    Tomkova M; Tomek J; Kriaucionis S; Schuster-Böckler B
    Genome Biol; 2018 Sep; 19(1):129. PubMed ID: 30201020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
    Islam SMA; Alexandrov LB
    Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG-->TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells.
    Lee DH; O'Connor TR; Pfeifer GP
    Nucleic Acids Res; 2002 Aug; 30(16):3566-73. PubMed ID: 12177298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Having a direct look: analysis of DNA damage and repair mechanisms by next generation sequencing.
    Meier B; Gartner A
    Exp Cell Res; 2014 Nov; 329(1):35-41. PubMed ID: 25131498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental systems for the analysis of mutational signatures: no 'one-size-fits-all' solution.
    Ivanov D; Hwang T; Sitko LK; Lee S; Gartner A
    Biochem Soc Trans; 2023 Jun; 51(3):1307-1317. PubMed ID: 37283472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Signatures in Breast Cancer: The Problem at the DNA Level.
    Nik-Zainal S; Morganella S
    Clin Cancer Res; 2017 Jun; 23(11):2617-2629. PubMed ID: 28572256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
    Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of mutational signature software on correlated signatures.
    Wu Y; Chua EHZ; Ng AWT; Boot A; Rozen SG
    Sci Rep; 2022 Jan; 12(1):390. PubMed ID: 35013428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.
    Haradhvala NJ; Polak P; Stojanov P; Covington KR; Shinbrot E; Hess JM; Rheinbay E; Kim J; Maruvka YE; Braunstein LZ; Kamburov A; Hanawalt PC; Wheeler DA; Koren A; Lawrence MS; Getz G
    Cell; 2016 Jan; 164(3):538-49. PubMed ID: 26806129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
    Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
    Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding mutagenesis through delineation of mutational signatures in human cancer.
    Petljak M; Alexandrov LB
    Carcinogenesis; 2016 Jun; 37(6):531-40. PubMed ID: 27207657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.